Ubs Global Asset Management Americas Has Raised Its Puma Biotechnology (PBYI) Position; Charter Financial (CHFN) Covered By 2 Bullish Analysts Last Week

April 18, 2018 - By Peter Erickson

Charter Financial Corporation (NASDAQ:CHFN) Logo

Among 3 analysts covering Charter Financial Corp (NASDAQ:CHFN), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Charter Financial Corp had 4 analyst reports since September 21, 2015 according to SRatingsIntel. Keefe Bruyette & Woods downgraded Charter Financial Corporation (NASDAQ:CHFN) on Monday, November 7 to “Mkt Perform” rating. Zacks upgraded the shares of CHFN in report on Monday, September 21 to “Buy” rating. The rating was maintained by Sandler O’Neill on Wednesday, March 28 with “Buy”. See Charter Financial Corporation (NASDAQ:CHFN) latest ratings:

28/03/2018 Broker: Sandler O’Neill Rating: Buy New Target: $23.0000 Maintain

Ubs Global Asset Management Americas Inc increased Puma Biotechnology Inc (PBYI) stake by 11.09% reported in 2017Q4 SEC filing. Ubs Global Asset Management Americas Inc acquired 1,837 shares as Puma Biotechnology Inc (PBYI)’s stock declined 33.20%. The Ubs Global Asset Management Americas Inc holds 18,400 shares with $1.82 billion value, up from 16,563 last quarter. Puma Biotechnology Inc now has $2.54 billion valuation. The stock increased 0.60% or $0.4 during the last trading session, reaching $67.2. About 45,008 shares traded. Puma Biotechnology, Inc. (NYSE:PBYI) has risen 66.84% since April 18, 2017 and is uptrending. It has outperformed by 55.29% the S&P500.

Investors sentiment increased to 1.65 in 2017 Q4. Its up 0.10, from 1.55 in 2017Q3. It improved, as 13 investors sold PBYI shares while 50 reduced holdings. 40 funds opened positions while 64 raised stakes. 34.70 million shares or 2.80% less from 35.70 million shares in 2017Q3 were reported. Moreover, Hsbc Public Ltd Liability Corporation has 0% invested in Puma Biotechnology, Inc. (NASDAQ:PBYI) for 2,430 shares. 60,770 were accumulated by Alliancebernstein Limited Partnership. Public Employees Retirement Association Of Colorado stated it has 0% of its portfolio in Puma Biotechnology, Inc. (NASDAQ:PBYI). Cornerstone Cap Mgmt Hldgs Limited Liability has invested 0.01% in Puma Biotechnology, Inc. (NASDAQ:PBYI). Redwood Invs Lc stated it has 179,595 shares or 1.25% of all its holdings. Emory University has invested 1.45% in Puma Biotechnology, Inc. (NASDAQ:PBYI). Strs Ohio accumulated 14,200 shares. Canada Pension Plan Investment Board invested in 35,100 shares or 0.01% of the stock. Retail Bank Of America Corporation De invested 0% in Puma Biotechnology, Inc. (NASDAQ:PBYI). Eam Investors Ltd Liability invested in 17,987 shares. Atlantic Grp Limited Liability invested in 0% or 463 shares. Fmr Ltd stated it has 1.71M shares or 0.02% of all its holdings. Legal & General Public Limited Com holds 12,688 shares. Sio Limited Liability Corporation holds 0.68% in Puma Biotechnology, Inc. (NASDAQ:PBYI) or 12,209 shares. Adage Capital Ptnrs Ltd Limited Liability Company holds 0.5% in Puma Biotechnology, Inc. (NASDAQ:PBYI) or 2.22M shares.

Ubs Global Asset Management Americas Inc decreased United Theraputics (NASDAQ:UTHR) stake by 5,288 shares to 119,449 valued at $17.67 billion in 2017Q4. It also reduced Healthsouth Corp (NYSE:HLS) stake by 18,742 shares and now owns 57,786 shares. Alkermes Plc Ord (NASDAQ:ALKS) was reduced too.

Since January 22, 2018, it had 0 buys, and 4 sales for $1.40 million activity. EYLER CHARLES R also sold $62,117 worth of Puma Biotechnology, Inc. (NASDAQ:PBYI) on Monday, January 22. On Monday, January 22 the insider AUERBACH ALAN H sold $991,683. Another trade for 1,860 shares valued at $172,515 was sold by BRYCE RICHARD PAUL. $172,515 worth of stock was sold by Lo Steven on Monday, January 22.

Among 11 analysts covering Puma Biotechnology Inc (NYSE:PBYI), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Puma Biotechnology Inc had 61 analyst reports since August 27, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Thursday, November 9. The stock of Puma Biotechnology, Inc. (NASDAQ:PBYI) has “Buy” rating given on Wednesday, January 24 by Bank of America. The firm has “Buy” rating given on Tuesday, July 18 by Credit Suisse. The stock of Puma Biotechnology, Inc. (NASDAQ:PBYI) has “Buy” rating given on Wednesday, July 19 by Leerink Swann. Leerink Swann maintained the shares of PBYI in report on Monday, July 10 with “Outperform” rating. On Wednesday, January 24 the stock rating was maintained by Stifel Nicolaus with “Buy”. As per Wednesday, September 27, the company rating was maintained by Credit Suisse. The stock of Puma Biotechnology, Inc. (NASDAQ:PBYI) earned “Buy” rating by Citigroup on Monday, December 14. The stock of Puma Biotechnology, Inc. (NASDAQ:PBYI) earned “Neutral” rating by Citigroup on Thursday, September 3. On Friday, March 2 the stock rating was maintained by Cowen & Co with “Hold”.

The stock decreased 0.05% or $0.01 during the last trading session, reaching $21.44. About 259 shares traded. Charter Financial Corporation (NASDAQ:CHFN) has risen 6.01% since April 18, 2017 and is uptrending. It has underperformed by 5.54% the S&P500.

Charter Financial Corporation operates as the holding firm for CharterBank, a federally-chartered savings bank that provides various banking services and products to individuals and businesses in the United States. The company has market cap of $324.44 million. The companyÂ’s deposit products include checking, money market, regular savings, and term certificate accounts, as well as noninterest-bearing demand deposits. It has a 23.53 P/E ratio. It also provides commercial real estate loans, one- to four-family residential mortgage loans, construction loans, and investment securities; and commercial business loans, home equity loans, and lines of credit, as well as other consumer loans, including deposits, automobile loans, mobile home loans, and various other installment loans.

Investors sentiment decreased to 1.05 in Q4 2017. Its down 0.31, from 1.36 in 2017Q3. It dropped, as 10 investors sold Charter Financial Corporation shares while 28 reduced holdings. 11 funds opened positions while 29 raised stakes. 9.70 million shares or 1.02% more from 9.60 million shares in 2017Q3 were reported. Wells Fargo Co Mn reported 0% in Charter Financial Corporation (NASDAQ:CHFN). Ameritas Inv reported 0% in Charter Financial Corporation (NASDAQ:CHFN). 8,294 were reported by Amer Gp. Millennium Limited Com reported 103,644 shares stake. Strs Ohio accumulated 10,800 shares. Wellington Mngmt Gp Limited Liability Partnership, a Massachusetts-based fund reported 99,440 shares. Renaissance Technology Limited Liability Corp invested in 1.05 million shares. Invesco owns 127,021 shares or 0% of their US portfolio. Geode Capital Mgmt accumulated 129,393 shares. Brandywine Glob Inv Ltd Liability Corporation invested 0% of its portfolio in Charter Financial Corporation (NASDAQ:CHFN). Mackenzie Financial Corp invested in 20,308 shares. Zacks Invest Mgmt accumulated 134,583 shares or 0.05% of the stock. 37,044 are owned by Arrowstreet Capital Lp. Price T Rowe Assoc Md has 0% invested in Charter Financial Corporation (NASDAQ:CHFN) for 260,617 shares. Mutual Of America Cap Ltd Limited Liability Company holds 277,728 shares or 0.07% of its portfolio.

Charter Financial Corporation (NASDAQ:CHFN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>